Life Sciences

Japan has one of the world’s fastest growing elderly populations, driving growth in the huge Life Sciences market. In 2010, almost a quarter of Japan’s 127 million people were over 65. And this is predicted to increase to over 30% by 2025 and to 40% by 2055. Japanese society is therefore facing an increasing number of chronic and long-term diseases. After the US, Japan has the second largest healthcare, pharmaceutical and medical devices markets in the world. Total medical expenditure is over £250 billion a year and the Japanese pharmaceutical market is bigger than both France and Germany's combined.

For the healthcare market, unique, sophisticated, and highly technical products are sought to assist elderly people, ranging from healthy elderly people to those with disabilities. For the medical devices market, opportunities exist with advanced and innovative products for exports of finished products, joint R&D and technology licensing-out. In pharmaceuticals, the demand for joint development, outsourcing of R&D, clinical trials and regulatory affairs to Europe continues to increase. For more see UK Trade & Investment's Introduction to Healthcare & Medical Devices in Japan and Introduction to Biotechnology & Pharmaceuticals in Japan.

Japan Time
Jun 23
2014
UK Time
Jun 23
2014

Meet Our Life Sciences Officer At BIO US

Meet Kaori Arai, Japan-based Life Sciences senior trade adviser, at BIO US from 23-26 June in San Diego, USA.
23 - 26 June 2014
23 - 26 June 2014
4 day event | US time
4 day event | US time
San Diego
Free

UK bio and pharmaceutical-related companies looking to enter the Japanese market will have an opportunity to meet Japan-based Life Sciences senior trade adviser, Kaori Arai, at BIO US from 23-26 June in San Diego, USA. 

Japan Time
Jan 12
2015
UK Time
Jan 12
2015

Regenerative Medicine Trade Mission to Japan

UKTI Regenerative Medicine Trade Mission to Japan - January 2015
w/c 12 January 2015
w/c 12 January 2015
Multiple days | Japan time
Multiple days | Japan time
Tokyo & Osaka
Please contact for full details

November 2014 will see a reform in regulation in the area of regenerative medicine implemented in Japan, allowing for an accelerated path to market entry. This trade mission will provide great opportunities for UK companies to identify key business opportunities with Japanese companies and to establish a network with academia, industry and Japanese regulatory authorities.

Japan Time
Nov 19
2014
UK Time
Nov 19
2014

17th Tokyo International Industry Exhibition 2014

17th Tokyo International Industrial Exhibition 2014
19-21 November 2014
19-21 November 2014
3 day event | Japan time
3 day event | Japan time
Tokyo
Please see external site for full details

Join the 17th Tokyo International Industry Exhibition 2014, one of the largest trade shows in Japan for small and medium-sized businesses.  The Tokyo Metropolitan Government will provide a booth and business matching service for foreign companies interested in establishing business operations in Tokyo or in doing business with Tokyo-based companies. 

Japan Time
Nov 07
2014
UK Time
Nov 07
2014

CNS Trade Mission To Japan

Explore key business opportunities related to treatment of CNS (Central Nervous System) diseases at 'CNS Mission to Japan'
7 November 2014
7 November 2014
1 week mission | Japan time
1 week mission | Japan time
Tokyo
Please contact for full details

Explore key business opportunities related to treatment of CNS (Central Nervous System) diseases at 'CNS Trade Mission to Japan', a trade mission which will be held in the week commencing 3 November 2014. This market visit provides great opportunities for the UK companies to explore key business opportunities with Japanese companies.

Industry Insight: Chemicals Sector In Japan

Understand the opportunities and potential for your company in the Japanese chemicals industry

Chemical companies here have been shifting from manufacturing commodity products to high value-added specialty chemicals, in particular for the booming pharmaceutical sector, which offers opportunities for British firms in the outsourced manufacturing of active ingredients and intermediaries, according to the London-based Chemical Industries Association. 

Pages